Sarcoidosis

HomePatientsLung Disease Week at the ATS2015 ▶ Sarcoidosis
Sarcoidosis Week

Sarcoidosis Week

Welcome to Sarcoidosis Week at the ATS!

The American Thoracic Society in collaboration with the Foundation for Sarcoidosis Research is excited to embark upon “Sarcoidosis Week at the ATS.” 

Sarcoidosis is an inflammatory disease that most commonly involves the lungs but can impact any organ in the body including the eyes, nervous system, liver and heart.  For some patients, the disease is mild and for others it may be progressive and devastating. The cause of sarcoidosis remains unknown; however, experts suspect that sarcoidosis develops when a patient’s immune system overreacts to some type of exposure—occupational, environmental or infectious—and small clumps of inflammatory cells called granulomas are formed and deposited in affected organs.  Whether an individual’s unique genetic make up influences who develops the disease, or how the disease evolves is also not well understood.

The American Thoracic Society and the Foundation for Sarcoidosis Research have partnered to engage and support clinicians, scientific investigators and patients to promote sarcoidosis research, education and advocacy.  We seek to increase awareness among patients and clinicians regarding the current state of the art in diagnosis and management, and also to advance research into the causes, novel therapies, and prevention of sarcoidosis. Working collaboratively, we strive to improve patient care and treatment options for this potentially devastating disease.

Carrie A. Redlich, MD

Carrie A. Redlich, MD
Chair
Environ. & Occupational Health Cmte
Member, ATS Board of Directors

Andrea Wilson

Andrea Wilson
Co-Founder and Chairwoman
Foundation for Sarcoidosis Research
Member, ATS Public Advisory Roundtable

ATS Sarcoidosis PARtner
Foundation for Sarcoidosis Research

image

The Foundation for Sarcoidosis Research (FSR) is the nation’s leading nonprofit organization dedicated to finding a cure for this disease and to improving care for sarcoidosis patients. Since its establishment in 2000, FSR has funded numerous domestic and international research efforts and has worked diligently to provide resources to thousands. FSR provides funding and collaborations for research and initiatives which focus on the understanding of sarcoidosis, addresses the causes of the disease, counters the suffering of patients, and advances the potential for a cure.